Ligand Pharmaceuticals (NASDAQ: LGND) Could Move Higher in the Short-Term
Our target potential upside is 16% to 26% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Dec 15, 2020
Our target potential upside is 16% to 26% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Dec 14, 2020
Our target potential upside is nearly 11% to 33% in the next 3-5 months.
Read MorePosted by Tara Young, Trades Of The Day | Dec 11, 2020
Our target potential upside is nearly 27% to 88% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Dec 10, 2020
Our target potential upside is nearly 7% to 13% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Dec 9, 2020
Our target potential upside is 5% to 17% in the next 4-6 months.
Read More